|
Volume 9 Issue 5
|
|
Comment |
|
|
Live or let die: oestrogen regulation of survival signalling in endocrine response
Alison J Butt, Robert L Sutherland, Elizabeth A Musgrove Breast Cancer Research 2007, 9:306 (26 October 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Clinical trial update: implications and management of residual disease after neoadjuvant therapy for breast cancer
Erica L Mayer, Lisa A Carey, Harold J Burstein Breast Cancer Research 2007, 9:110 (12 September 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Transphosphorylation of kinase-dead HER3 and breast cancer progression: a new standpoint or an old concept revisited?
Javier A Menendez, Ruth Lupu Breast Cancer Research 2007, 9:111 (19 October 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Clinical trials update: endocrine and biological therapy combinations in the treatment of breast cancer
Alexandra F Leary, Bhawna Sirohi, Stephen RD Johnston Breast Cancer Research 2007, 9:112 (26 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
Review |
|
|
Breast cancer risk-assessment models
D Gareth R Evans, Anthony Howell Breast Cancer Research 2007, 9:213 (12 September 2007)
Abstract | Full text | PDF | PubMed
|
|
|
P-cadherin expression in breast cancer: a review
Joana Paredes, Ana Correia, Ana Ribeiro, André Albergaria, Fernanda Milanezi, Fernando C Schmitt Breast Cancer Research 2007, 9:214 (31 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
Research |
|
|
Role of human HGFIN/nmb in breast cancer
Rebecca L Metz, Prem S Patel, Meera Hameed, Margaret Bryan, Pranela Rameshwar Breast Cancer Research 2007, 9:R58 (10 September 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers
Christina Yau, Vita Fedele, Ritu Roydasgupta, Jane Fridlyand, Alan Hubbard, Joe W Gray, Karen Chew, Shanaz H Dairkee, Dan H Moore, Francesco Schittulli, Stefania Tommasi, Angelo Paradiso, Donna G Albertson, Christopher C Benz Breast Cancer Research 2007, 9:R59 (12 September 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Epigenetic transcriptome changes, more than genotypic variation, account for age-associated differences in the incidence and prognosis of sporadic hormone-dependant breast cancer, according to microarray study.
|
|
|
BP1 transcriptionally activates bcl-2 and inhibits TNFα-induced cell death in MCF7 breast cancer cells
Holly S Stevenson, Sidney W Fu, Joseph J Pinzone, Jinguen Rheey, Samuel J Simmens, Patricia E Berg Breast Cancer Research 2007, 9:R60 (13 September 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy
Anna L Stratford, Golareh Habibi, Arezoo Astanehe, Helen Jiang, Kaiji Hu, Eugene Park, Ashleen Shadeo, Timon PH Buys, Wan Lam, Trevor Pugh, Marco Marra, Torsten O Nielsen, Uwe Klinge, Peter R Mertens, Samuel Aparicio, Sandra E Dunn Breast Cancer Research 2007, 9:R61 (17 September 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Epidermal growth factor receptor inhibition combined with Y-box binding protein suppression presents a potential therapeutic target for basal-like breast cancers, for which there are currently no targeted therapies.
|
|
|
Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004
Theresa HM Keegan, Ellen T Chang, Esther M John, Pamela L Horn-Ross, Margaret R Wrensch, Sally L Glaser, Christina A Clarke Breast Cancer Research 2007, 9:R62 (25 September 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Autocrine WNT signaling contributes to breast cancer cell proliferation via the canonical WNT pathway and EGFR transactivation
Thomas Schlange, Yutaka Matsuda, Susanne Lienhard, Alexandre Huber, Nancy E Hynes Breast Cancer Research 2007, 9:R63 (26 September 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Therapeutic interference with autocrine wingless and integration site growth factor (WNT) signaling in combination with other targeted therapies may improve the efficiency of breast cancer treatments.
|
|
|
Comparison of different commercial kits for HER2 testing in breast cancer: looking for the accurate cutoff for amplification
Anne Cayre, Florence Mishellany, Nicole Lagarde, Frédérique Penault-Llorca Breast Cancer Research 2007, 9:R64 (1 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Comparison of four commercially available HER2 testing kits identified possible alternatives to dual-probe FISH kits to determine overexpression of HER2 for targeting breast cancer treatment.
|
|
|
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Bas Kreike, Marieke van Kouwenhove, Hugo Horlings, Britta Weigelt, Hans Peterse, Harry Bartelink, Marc J van de Vijver Breast Cancer Research 2007, 9:R65 (2 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central | F1000 Medicine | F1000 Biology
|
|
|
A critical evaluation of loss of heterozygosity detected in tumor tissues, blood serum and bone marrow plasma from patients with breast cancer
Heidi Schwarzenbach, Volkmar Müller, Cord Beeger, Miriam Gottberg, Nicole Stahmann, Klaus Pantel Breast Cancer Research 2007, 9:R66 (3 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Intrinsic genetic characteristics determine tumor-modifying capacity of fibroblasts: matrix metalloproteinase-3 5A/5A genotype enhances breast cancer cell invasion
Deborah L Holliday, Simon Hughes, Jacqueline A Shaw, Rosemary A Walker, J Louise Jones Breast Cancer Research 2007, 9:R67 (8 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study
Marc van de Vijver, Michael Bilous, Wedad Hanna, Manfred Hofmann, Petra Kristel, Frédérique Penault-Llorca, Josef Rüschoff Breast Cancer Research 2007, 9:R68 (8 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling
Ana Quaglino, Carolina Schere-Levy, Leonardo Romorini, Roberto P Meiss, Edith C Kordon Breast Cancer Research 2007, 9:R69 (10 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Efficacy of adjuvant chemotherapy according to hormone receptor status in young patients with breast cancer: a pooled analysis
Jos A van der Hage, J Mieog, Marc J van de Vijver, Cornelis JH van de Velde, cooperating investigators of the European Organization for Research and Treatment of Cancer Breast Cancer Research 2007, 9:R70 (11 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
Editor’s summary
Chemotherapy alone is not a sufficient systemic treatment strategy in patients aged forty years or less with hormone receptor-positive breast cancer; hormone responsiveness is the key for tailoring their therapy.
|
|
|
Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism
Sailesh Gochhait, Syed Bukhari, Narendra Bairwa, Shivani Vadhera, Katayoon Darvishi, Mohammad Raish, Pawan Gupta, Syed Husain, Rameshwar NK Bamezai Breast Cancer Research 2007, 9:R71 (18 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
|
|
Dietary intake and breast density in high-risk women: a cross-sectional study
Marilyn Tseng, Celia Byrne, Kathryn A Evers, Mary B Daly Breast Cancer Research 2007, 9:R72 (19 October 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Different measures of smoking exposure and mammographic density in postmenopausal Norwegian women: a cross-sectional study
Yngve Bremnes, Giske Ursin, Nils Bjurstam, Inger T Gram Breast Cancer Research 2007, 9:R73 (26 October 2007)
Abstract | Full text | PDF | PubMed
|
|
|
Determination of HER2 status using both serum HER2 levels and circulating tumor cells in patients with recurrent breast cancer whose primary tumor was HER2 negative or of unknown HER2 status
Tanja Fehm, Sven Becker, Silke Duerr-Stoerzer, Karl Sotlar, Volkmar Mueller, Diethelm Wallwiener, Nancy Lane, Erich Solomayer, Jonathan Uhr Breast Cancer Research 2007, 9:R74 (26 October 2007)
Abstract | Full text | PDF | PubMed | Cited on BioMed Central
|
